- Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as…
karnottMay 30, 2025
Aortic aneurysms are potentially fatal focal enlargements of the aortic lumen; the disease burden is…
karnottMay 15, 2025
Repeat element viral mimicry is a common feature in pancreatic ductal adenocarcinoma (PDAC) that requires…
karnottMay 14, 2025
Kurt Jancsy, a junior majoring in biology and cognitive science at UMass Boston, has been…
karnottMay 13, 2025
Since the earliest days of her scientific career, Melina Claussnitzer, a metabolic disease researcher at…
karnottMay 13, 2025
Five Harvard Medical School researchers are among the 150 newly elected members of the National…
karnottMay 12, 2025
A major contributor to poor sensitivity to anti-cancer kinase inhibitor therapy is drug-induced cellular adaptation,…
karnottMay 12, 2025
Moyamoya disease — a rare, progressive condition that narrows the brain’s blood vessels — leads…
karnottMay 9, 2025
